“🌟베스트토토환전10초【평생베스트.com】베스트토토안전🌟”的搜索结果，显示 221-230 项，共有 8336 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL.

3. 传染病- 临床试验- 妙佑医疗国际

   This study is being conducted to determine gene and protein expression profiles (i.e. which genes and proteins are turned off and on) of those with a ...

4. 淋巴瘤- 医生与科室- 妙佑医疗国际

   设计和开展临床试验，以获得针对各种形式淋巴瘤的更有效且毒性更小的治疗方法 · 开发首个基因检测，帮助指导弥漫性大B 细胞淋巴瘤（最常见的非霍奇金淋巴瘤）的诊断和治疗 ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn., Jacksonville, Fla., Albert Lea, Minn. The puporse of this trial is to compare less intense hormone therapy and radiation therapy to usual ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a prospective, pilot, single arm study to evaluate the incidence of IIC in patients with solid malignancies receiving VSL#3 and ICIs.

7. 妙佑医疗国际 - CBD：安全有效？

   CBD 的益处是什么？使用是否安全？ 处方大麻二酚（CBD）油是一种有效的抗癫痫发作药物。然而，还需开展进一步研究 ...

8. 心血管医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to compare the fecal microbiota of patients with mild, moderate and severe Coronary Artery Disease (CAD) by ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...